Verastem, Inc.
THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE
Last updated:
Abstract:
This invention relates to methods comprising administering a FAK inhibitor and an immunotherapeutic agent such as anti-PD-1 or anti-PD-L1; that are useful in the treatment of abnormal cell growth, such as cancer, in mammals, especially humans.
Status:
Application
Type:
Utility
Filling date:
25 Nov 2019
Issue date:
22 Oct 2020